Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase 3 CELESTIAL trial.

Abou-Alfa G. K., Meyer T., Cheng A., El-Khoueiry A., Rimassa L., Ryoo B., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.36, no.15, 2018 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Volume: 36 Issue: 15
• Publication Date: 2018
• Doi Number: 10.1200/jco.2018.36.15_suppl.4019
• Journal Name: JOURNAL OF CLINICAL ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Trakya University Affiliated: Yes